Bristol-Myers Squibb Co (BMY)

63.84 -1.79  -2.73% NYSE Feb 24, 09:28 Delayed 2m USD

Bristol-Myers Squibb Price to Book Value:

8.480 for Feb. 24, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Price to Book Value Chart

Export Data
Save Image
Print Image

Historical Price to Book Value Data

View and export this data going back to 1972. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Feb. 24, 2020 8.480
Feb. 21, 2020 8.718
Feb. 20, 2020 8.657
Feb. 19, 2020 8.728
Feb. 18, 2020 8.776
Feb. 14, 2020 8.817
Feb. 13, 2020 8.777
Feb. 12, 2020 8.900
Feb. 11, 2020 8.898
Feb. 10, 2020 8.888
Feb. 7, 2020 8.80
Feb. 6, 2020 8.913
Feb. 5, 2020 8.712
Feb. 4, 2020 8.540
Feb. 3, 2020 8.445
Jan. 31, 2020 8.362
Jan. 30, 2020 8.476
Jan. 29, 2020 8.520
Jan. 28, 2020 8.609
Jan. 27, 2020 8.461
Jan. 24, 2020 8.522
Jan. 23, 2020 8.882
Jan. 22, 2020 8.957
Jan. 21, 2020 8.957
Jan. 17, 2020 8.862
Jan. 16, 2020 8.870
   
Jan. 15, 2020 8.844
Jan. 14, 2020 8.825
Jan. 13, 2020 8.787
Jan. 10, 2020 8.664
Jan. 9, 2020 8.694
Jan. 8, 2020 8.483
Jan. 7, 2020 8.492
Jan. 6, 2020 8.366
Jan. 3, 2020 8.339
Jan. 2, 2020 8.414
Dec. 31, 2019 8.526
Dec. 30, 2019 8.465
Dec. 27, 2019 8.520
Dec. 26, 2019 8.496
Dec. 24, 2019 8.390
Dec. 23, 2019 8.396
Dec. 20, 2019 8.436
Dec. 19, 2019 8.348
Dec. 18, 2019 8.388
Dec. 17, 2019 8.516
Dec. 16, 2019 8.435
Dec. 13, 2019 8.477
Dec. 12, 2019 8.493
Dec. 11, 2019 8.29
Dec. 10, 2019 8.248

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

Price to Book Value Benchmarks

Benchmarks
Amgen Inc 13.41
Biogen Inc 4.292
Gilead Sciences Inc 4.124

Price to Book Value Range, Past 5 Years

Minimum 4.359 Jul 22 2019
Maximum 9.592 Feb 15 2018
Average 6.771
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.